CorMedix

CRMD

Market cap $572M

7.24 USD

-0.12

1.63%

At close Updated Apr 10, 4:00 PM EDT

Pre-market

After hours

7.22

-0.02

0.28%

1 day

-1.63%

5 days

2.26%

1 month

7.74%

3 months

1.26%

6 months

-32.53%

Year to date

-40.46%

1 year

5.85%

5 years

-22.73%

10 years

-53.44%

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 191

Healthcare Biotechnology